Allelic variability in D21S11, but not in APP or APOE, is associated with cognitive decline in Down syndrome

被引:17
作者
Farrer, MJ
Crayton, L
Davies, GE
Oliver, C
Powell, J
Holland, AJ
Kessling, AM
机构
[1] UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,SCH MED,KENNEDY GALTON CTR,HARROW HA1 3UJ,MIDDX,ENGLAND
[2] ST MARKS NHS TRUST,HARROW HA1 3UJ,MIDDX,ENGLAND
[3] UNIV BIRMINGHAM,SCH PSYCHOL,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
[4] INST PSYCHIAT,LONDON SE5 8AF,ENGLAND
[5] UNIV CAMBRIDGE,DEPT PSYCHIAT,CAMBRIDGE CB2 2AH,ENGLAND
基金
英国惠康基金;
关键词
Alzheimer disease; apolipoprotein E; beta-amyloid; chromosome; 21; Down syndrome; genetics;
D O I
10.1097/00001756-199705060-00018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
GENETIC variation in the APOE gene and variation in chromosome 21 genotypes, including the APP locus, may influence age-associated cognitive decline in adults with Down syndrome. Molecular genetic and longitudinal neuropsychological analysis was performed for 41 unrelated Caucasian individuals (mean age 48.1 +/- 1.1 years (s.e.m.)) with free trisomy 21. Allele frequencies and genotype distributions were compared among subgroups with or without evidence of cognitive decline. Genetic variability at APOE and APP was not significantly associated with evidence of cognitive decline. However, aged individuals with Down syndrome, without evidence of cognitive decline, demonstrated unusual allelic variability at D21S11. These findings are discussed in the context of current hypotheses of Alzheimer-type dementia in Down syndrome and in the general population.
引用
收藏
页码:1645 / 1649
页数:5
相关论文
共 23 条
[1]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[2]  
BRAYNE C, 1988, LANCET, V1, P1265
[3]  
Cohen J., 1977, Statistical power analysis for the behavioral sciences, V2, P215, DOI [10.1016/B978-0-12-179060-8.50012-8, DOI 10.1016/B978-0-12-179060-8.50012-8]
[4]  
CRAYTON L, 1993, ALZHEIMER DIS DOWN S, P135
[5]   GENETIC-VARIATION IN THE COL6A1 REGION IS ASSOCIATED WITH CONGENITAL HEART-DEFECTS IN TRISOMY-21 (DOWNS-SYNDROME) [J].
DAVIES, GE ;
HOWARD, CM ;
FARRER, MJ ;
COLEMAN, MM ;
BENNETT, LB ;
CULLEN, LM ;
WYSE, RKH ;
BURN, J ;
WILLIAMSON, R ;
KESSLING, AM .
ANNALS OF HUMAN GENETICS, 1995, 59 :253-269
[6]   SEGREGATION OF A MISSENSE MUTATION IN THE AMYLOID PRECURSOR PROTEIN GENE WITH FAMILIAL ALZHEIMERS-DISEASE [J].
GOATE, A ;
CHARTIERHARLIN, MC ;
MULLAN, M ;
BROWN, J ;
CRAWFORD, F ;
FIDANI, L ;
GIUFFRA, L ;
HAYNES, A ;
IRVING, N ;
JAMES, L ;
MANT, R ;
NEWTON, P ;
ROOKE, K ;
ROQUES, P ;
TALBOT, C ;
PERICAKVANCE, M ;
ROSES, A ;
WILLIAMSON, R ;
ROSSOR, M ;
OWEN, M ;
HARDY, J .
NATURE, 1991, 349 (6311) :704-706
[7]  
HALLMAN DM, 1991, AM J HUM GENET, V49, P338
[8]   QUANTITATIVE-ANALYSIS OF SENILE PLAQUES IN ALZHEIMER-DISEASE - OBSERVATION OF LOG-NORMAL SIZE DISTRIBUTION AND MOLECULAR EPIDEMIOLOGY OF DIFFERENCES ASSOCIATED WITH APOLIPOPROTEIN-E GENOTYPE AND TRISOMY-21 (DOWN-SYNDROME) [J].
HYMAN, BT ;
WEST, HL ;
REBECK, GW ;
BULDYREV, SV ;
MANTEGNA, RN ;
UKLEJA, M ;
HAVLIN, S ;
STANLEY, HE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) :3586-3590
[9]  
JOBST KA, 1992, LANCET, V340, P1179
[10]  
Mann D. M. A., 1993, ALZHEIMER DIS DOWN S, P71